Douglas Kondziolka, MD
Approximately 30% of patients with melanoma will develop brain metastases; however, with the advancements of precise radiosurgery as well as combination systemic therapies, survival outcomes are improving.
State of the Science Summit on Melanoma and Immuno-Oncology.
OncLive: Please discuss the highlights of your presentation on brain metastases.
: Brain metastases are a very common cancer and, unfortunately, [are something] that means a lot for the patient and their family. A patient with cancer, whether it be melanoma or any type of cancer, is battling it and, hopefully, successfully. If they get the news that the cancer is now in the brain or spinal cord, that’s a scary thing. It means it could potentially affect function, who they are, what they are about, their ability to walk, memory, speech, and vision. It means a lot and, often, they are aware of the fact that if the cancer is in the brain, sometimes that affects survival.
... to read the full story